1887

Abstract

The core region of the hepatitis C virus (HCV) genome possesses an overlapping ORF that has been shown to encode a protein, known as the alternate reading frame protein (ARFP), F or core+1. The biological role of this protein remains elusive, as it appears to be non-essential for virus replication. However, a number of independent studies have shown that the ARFP/F/core+1 protein elicits humoral and cellular immune responses in HCV-infected individuals and interacts with important cellular proteins. To assess the significance of the core+1 humoral response in HCV-infected patients, we examined the prevalence of anti-core+1 antibodies in sera from patients with hepatocellular carcinoma (HCC) in comparison with chronically HCV-infected individuals without HCC. We produced two HCV core+1 histidine-tagged recombinant proteins for genotypes 1a (aa 11–160) and 1b (aa 11–144), as well as a non-tagged highly purified recombinant core+1/S protein (aa 85–144) of HCV-1b. Using an in-house ELISA, we tested the prevalence of core+1 antibodies in 45 patients with HCC in comparison with 47 chronically HCV-infected patients without HCC and 77 negative-control sera. More than 50 % of the serum samples from HCC patients reacted with all core+1 antigens, whereas <26 % of the sera from the non-HCC HCV-infected individuals tested positive. No core+1-specific reactivity was detected in any of the control samples. In conclusion, the high occurrence of anti-core+1 antibodies in the serum of HCC patients suggests a role for the ARFP/F/core+1 protein in the pathogenesis of HCC.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.023010-0
2011-06-01
2020-07-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/6/1343.html?itemId=/content/journal/jgv/10.1099/vir.0.023010-0&mimeType=html&fmt=ahah

References

  1. Bain C., Parroche P., Lavergne J. P., Duverger B., Vieux C., Dubois V., Komurian-Pradel F., Trépo C., Gebuhrer L. et al. 2004; Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J Virol 78:10460–10469 [CrossRef][PubMed]
    [Google Scholar]
  2. Baril M., Brakier-Gingras L. 2005; Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein. Nucleic Acids Res 33:1474–1486 [CrossRef][PubMed]
    [Google Scholar]
  3. Bartenschlager R., Frese M., Pietschmann T. 2004; Novel insights into hepatitis C virus replication and persistence. Adv Virus Res 63:71–180 [CrossRef][PubMed]
    [Google Scholar]
  4. Basu A., Steele R., Ray R., Ray R. B. 2004; Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus. J Gen Virol 85:2299–2306 [CrossRef][PubMed]
    [Google Scholar]
  5. Boulant S., Becchi M., Penin F., Lavergne J. P. 2003; Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem 278:45785–45792 [CrossRef][PubMed]
    [Google Scholar]
  6. Boumlic A., Nominé Y., Charbonnier S., Dalagiorgou G., Vassilaki N., Kieffer B., Travé G., Mavromara P., Orfanoudakis G. 2010; Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein. FEBS J 277:774–789 [CrossRef][PubMed]
    [Google Scholar]
  7. Boumlic A., Vassilaki N., Dalagiorgou G., Kochlios E., Kakkanas A., Georgopoulou U., Markoulatos P., Orfanoudakis G., Mavromara P. 2011; Internal translation initiation stimulates expression of the ARF/core+1 open reading frame of HCV genotype 1b. Virus Res 155:213–220[PubMed] [CrossRef]
    [Google Scholar]
  8. Branch A. D., Stump D. D., Gutierrez J. A., Eng F., Walewski J. L. 2005; The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others. Semin Liver Dis 25:105–117 [CrossRef][PubMed]
    [Google Scholar]
  9. Choi J., Xu Z., Ou J. H. 2003; Triple decoding of hepatitis C virus RNA by programmed translational frameshifting. Mol Cell Biol 23:1489–1497 [CrossRef][PubMed]
    [Google Scholar]
  10. Chuang W. C., Allain J. P. 2008; Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections. J Gen Virol 89:1890–1900 [CrossRef][PubMed]
    [Google Scholar]
  11. Cohen M., Bachmatov L., Ben-Ari Z., Rotman Y., Tur-Kaspa R., Zemel R. 2007; Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection. Dig Dis Sci 52:2427–2432 [CrossRef][PubMed]
    [Google Scholar]
  12. Di Bisceglie A. M. 2000; Natural history of hepatitis C: its impact on clinical management. Hepatology 31:1014–1018 [CrossRef][PubMed]
    [Google Scholar]
  13. Eng F. J., Walewski J. L., Klepper A. L., Fishman S. L., Desai S. M., McMullan L. K., Evans M. J., Rice C. M., Branch A. D. 2009; Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms. J Virol 83:3104–3114 [CrossRef][PubMed]
    [Google Scholar]
  14. Fiorucci M., Boulant S., Fournillier A., Abraham J. D., Lavergne J. P., Paranhos-Baccala G., Inchauspé G., Bain C. 2007; Expression of the alternative reading frame protein of hepatitis C virus induces cytokines involved in hepatic injuries. J Gen Virol 88:1149–1162 [CrossRef][PubMed]
    [Google Scholar]
  15. Fishman S. L., Factor S. H., Balestrieri C., Fan X., Dibisceglie A. M., Desai S. M., Benson G., Branch A. D. 2009; Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma. Clin Cancer Res 15:3205–3213 [CrossRef][PubMed]
    [Google Scholar]
  16. Hoofnagle J. H. 2002; Course and outcome of hepatitis C. Hepatology 36:Suppl. 1S21–S29 [CrossRef][PubMed]
    [Google Scholar]
  17. Houghton M., Abrignani S. 2005; Prospects for a vaccine against the hepatitis C virus. Nature 436:961–966 [CrossRef][PubMed]
    [Google Scholar]
  18. Ikeda K., Saitoh S., Koida I., Arase Y., Tsubota A., Chayama K., Kumada H., Kawanishi M. 1993; A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18:47–53 [CrossRef][PubMed]
    [Google Scholar]
  19. Kalamvoki M., Georgopoulou U., Mavromara P. 2006; The NS5A protein of the hepatitis C virus genotype 1a is cleaved by caspases to produce C-terminal-truncated forms of the protein that reside mainly in the cytosol. J Biol Chem 281:13449–13462 [CrossRef][PubMed]
    [Google Scholar]
  20. Komurian-Pradel F., Rajoharison A., Berland J. L., Khouri V., Perret M., Van Roosmalen M., Pol S., Negro F., Paranhos-Baccalà G. 2004; Antigenic relevance of F protein in chronic hepatitis C virus infection. Hepatology 40:900–909[PubMed] [CrossRef]
    [Google Scholar]
  21. Lemon S. M., Lerat H., Weinman S. A., Honda M. 2000; A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans. Trans Am Clin Climatol Assoc 111:146–156, discussion 156–157[PubMed]
    [Google Scholar]
  22. Lerat H., Honda M., Beard M. R., Loesch K., Sun J., Yang Y., Okuda M., Gosert R., Xiao S. Y., Weinman S. 2002; Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122:352–365 [CrossRef][PubMed]
    [Google Scholar]
  23. McMullan L. K., Grakoui A., Evans M. J., Mihalik K., Puig M., Branch A. D., Feinstone S. M., Rice C. M. 2007; Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci U S A 104:2879–2884 [CrossRef][PubMed]
    [Google Scholar]
  24. Moradpour D., Penin F., Rice C. M. 2007; Replication of hepatitis C virus. Nat Rev Microbiol 5:453–463 [CrossRef][PubMed]
    [Google Scholar]
  25. Morice Y., Ratinier M., Miladi A., Chevaliez S., Germanidis G., Wedemeyer H., Laperche S., Lavergne J. P., Pawlotsky J. M. 2009; Seroconversion to hepatitis C virus alternate reading frame protein during acute infection. Hepatology 49:1449–1459 [CrossRef][PubMed]
    [Google Scholar]
  26. Pavio N., Battaglia S., Boucreux D., Arnulf B., Sobesky R., Hermine O., Brechot C. 2005; Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-β pathway. Oncogene 24:6119–6132 [CrossRef][PubMed]
    [Google Scholar]
  27. Pawlotsky, J. M., Morice, Y., Miladi, A., Lavergne, J., Germanidis, G. & Penin, F. (2005 Seroconversion profiles against alternative frameshift protein F of Hepatitis C virus in acute phase infection from unique sources demonstrates F protein production and points to differential expression in different patients. In 12th International Symposium on HCV and Related Viruses, Montreal, Quebec, Canada
  28. Simmonds P. 1995; Variability of hepatitis C virus. Hepatology 21:570–583 [CrossRef][PubMed]
    [Google Scholar]
  29. Simmonds P., Bukh J., Combet C., Deléage G., Enomoto N., Feinstone S., Halfon P., Inchauspé G., Kuiken C. et al. 2005; Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962–973 [CrossRef][PubMed]
    [Google Scholar]
  30. Smith D. B., Simmonds P. 1997; Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol 45:238–246 [CrossRef][PubMed]
    [Google Scholar]
  31. Sobesky R., Feray C., Rimlinger F., Derian N., Dos Santos A., Roque-Afonso A. M., Samuel D., Bréchot C., Thiers V. 2007; Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology 46:1704–1712 [CrossRef][PubMed]
    [Google Scholar]
  32. Troesch M., Jalbert E., Canobio S., Boulassel M. R., Routy J. P., Bernard N. F., Bruneau J., Lapointe N., Boucher M., Soudeyns H. 2005; Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1. AIDS 19:775–784 [CrossRef][PubMed]
    [Google Scholar]
  33. Tsao M. L., Chao C. H., Yeh C. T. 2006; Interaction of hepatitis C virus F protein with prefoldin 2 perturbs tubulin cytoskeleton organization. Biochem Biophys Res Commun 348:271–277 [CrossRef][PubMed]
    [Google Scholar]
  34. van Regenmortel M. H., Mayo M. A., Fauquet C. M., Maniloff J. 2000; Virus nomenclature: consensus versus chaos. Arch Virol 145:2227–2232 [CrossRef][PubMed]
    [Google Scholar]
  35. Varaklioti A., Vassilaki N., Georgopoulou U., Mavromara P. 2002; Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem 277:17713–17721 [CrossRef][PubMed]
    [Google Scholar]
  36. Vassilaki N., Mavromara P. 2003; Two alternative translation mechanisms are responsible for the expression of the HCV ARFP/F/core+1 coding open reading frame. J Biol Chem 278:40503–40513 [CrossRef][PubMed]
    [Google Scholar]
  37. Vassilaki N., Mavromara P. 2009; The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product. IUBMB Life 61:739–752 [CrossRef][PubMed]
    [Google Scholar]
  38. Vassilaki N., Boleti H., Mavromara P. 2007; Expression studies of the core+1 protein of the hepatitis C virus 1a in mammalian cells. The influence of the core protein and proteasomes on the intracellular levels of core+1. FEBS J 274:4057–4074 [CrossRef][PubMed]
    [Google Scholar]
  39. Vassilaki N., Boleti H., Mavromara P. 2008a). Expression studies of the HCV-1a core+1 open reading frame in mammalian cells. Virus Res 133:123–135 [CrossRef][PubMed]
    [Google Scholar]
  40. Vassilaki N., Friebe P., Meuleman P., Kallis S., Kaul A., Paranhos-Baccalà G., Leroux-Roels G., Mavromara P., Bartenschlager R. 2008b). Role of the hepatitis C virus core+1 open reading frame and core cis-acting RNA elements in viral RNA translation and replication. J Virol 82:11503–11515 [CrossRef][PubMed]
    [Google Scholar]
  41. Vassilaki N., Kalliampakou K. I., Mavromara P. 2008c). Differences in the expression of the hepatitis C virus core+1 open reading frame between a nuclear and a cytoplasmic expression system. J Gen Virol 89:222–231 [CrossRef][PubMed]
    [Google Scholar]
  42. Walewski J. L., Keller T. R., Stump D. D., Branch A. D. 2001; Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7:710–721 [CrossRef][PubMed]
    [Google Scholar]
  43. Wu W. B., Shao S. W., Zhao L. J., Luan J., Cao J., Gao J., Zhu S. Y., Qi Z. T. 2007; Hepatitis C virus F protein up-regulates c-myc and down-regulates p53 in human hepatoma HepG2 cells. Intervirology 50:341–346 [CrossRef][PubMed]
    [Google Scholar]
  44. Xu Z., Choi J., Yen T. S., Lu W., Strohecker A., Govindarajan S., Chien D., Selby M. J., Ou J. 2001; Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 20:3840–3848 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.023010-0
Loading
/content/journal/jgv/10.1099/vir.0.023010-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error